用于实验治疗的晚期自发性转移的小鼠模型。
Mouse models of advanced spontaneous metastasis for experimental therapeutics.
机构信息
The Molecular & Cellular Biology Research, Sunnybrook Health Science Centre, Toronto, Ontario M4N 3M5, Canada.
出版信息
Nat Rev Cancer. 2011 Feb;11(2):135-41. doi: 10.1038/nrc3001.
Abstract
An enduring problem in cancer research is the failure to reproduce highly encouraging preclinical therapeutic findings using transplanted or spontaneous primary tumours in mice in clinical trials of patients with advanced metastatic disease. There are several reasons for this, including the failure to model established, visceral metastatic disease. We therefore developed various models of aggressive multi-organ spontaneous metastasis after surgical resection of orthotopically transplanted human tumour xenografts. In this Opinion article we provide a personal perspective summarizing the prospect of their increased clinical relevance. This includes the reduced efficacy of certain targeted anticancer drugs, the late emergence of spontaneous brain metastases and the clinical trial results evaluating a highly effective therapeutic strategy previously tested using such models.
摘要
癌症研究中一个持久存在的问题是，在晚期转移性疾病患者的临床试验中，使用移植或自发的原发性肿瘤在小鼠中重现高度有希望的临床前治疗发现的失败。造成这种情况的原因有几个，包括未能建立已建立的内脏转移性疾病模型。因此，我们开发了各种模型，用于模拟在同种异体移植人肿瘤异种移植物切除后发生的侵袭性多器官自发转移。在这篇观点文章中，我们提供了一个个人视角，总结了它们增加临床相关性的前景。这包括某些靶向抗癌药物疗效降低、自发性脑转移的迟发以及临床试验结果，这些结果评估了之前使用此类模型测试的一种非常有效的治疗策略。
相似文献
1
Mouse models of advanced spontaneous metastasis for experimental therapeutics.用于实验治疗的晚期自发性转移的小鼠模型。
Nat Rev Cancer. 2011 Feb;11(2):135-41. doi: 10.1038/nrc3001.
2
On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.用于抗癌药物测试的晚期内脏转移性疾病小鼠模型的开发
Cancer Metastasis Rev. 2007 Dec;26(3-4):737-47. doi: 10.1007/s10555-007-9087-6.
3
A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.开发晚期或早期自发转移临床前模型以研究抗血管生成药物、节拍化疗和肿瘤微环境的十年经验。
Cancer J. 2015 Jul-Aug;21(4):274-83. doi: 10.1097/PPO.0000000000000134.
4
Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic.用于抗癌药物发现与评估的原位转移小鼠模型：通往临床的桥梁。
Invest New Drugs. 1999;17(4):343-59. doi: 10.1023/a:1006326203858.
5
Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived-but they can be improved.人肿瘤异种移植作为人类抗癌药物活性的预测性临床前模型：比通常认为的要好——但仍有改进空间。
Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S134-9.
6
Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.明显自发性乳腺癌转移的患者来源异种移植模型的开发：一则警示
PLoS One. 2016 Jun 29;11(6):e0158034. doi: 10.1371/journal.pone.0158034. eCollection 2016.
7
Clonogenic assay with established human tumour xenografts: correlation of in vitro to in vivo activity as a basis for anticancer drug discovery.用人源肿瘤异种移植模型进行克隆形成试验：体外与体内活性的相关性作为抗癌药物发现的基础
Eur J Cancer. 2004 Apr;40(6):802-20. doi: 10.1016/j.ejca.2004.01.009.
8
Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis.使用早期或晚期乳腺癌转移模型对抗血管生成药物临床疗效进行临床前再现。
Breast. 2013 Aug;22 Suppl 2:S57-65. doi: 10.1016/j.breast.2013.07.011.
9
Contemporary pre-clinical development of anticancer agents--what are the optimal preclinical models?当代抗癌药物的临床前开发——什么样的临床前模型是最佳的？
Eur J Cancer. 2009 Nov;45(16):2768-81. doi: 10.1016/j.ejca.2009.08.008. Epub 2009 Sep 15.
10
The relevance of animal tumour models to the preclinical screening of cytokines.动物肿瘤模型与细胞因子临床前筛选的相关性。
Cancer Surv. 1989;8(4):741-54.
引用本文的文献
1
Spontaneous and experimental models of lymph node metastasis.淋巴结转移的自发和实验模型。
Nat Protoc. 2025 Aug 13. doi: 10.1038/s41596-025-01200-5.
2
From lab to life: technological innovations in transforming cancer metastasis detection and therapy.从实验室到临床：癌症转移检测与治疗变革中的技术创新
Discov Oncol. 2025 Aug 10;16(1):1517. doi: 10.1007/s12672-025-02910-8.
3
Rhodiola crenulata induces apoptosis in bone metastatic breast cancer cells via activation of caspase-9 and downregulation of MtMP activity.红景天通过激活半胱天冬酶-9和下调线粒体膜电位活性诱导骨转移性乳腺癌细胞凋亡。
Sci Rep. 2025 Mar 18;15(1):9341. doi: 10.1038/s41598-025-93274-0.
4
Deleting autotaxin in LysM+ myeloid cells impairs innate tumor immunity in models of metastatic melanoma.在LysM+髓样细胞中删除自分泌运动因子会损害转移性黑色素瘤模型中的先天性肿瘤免疫。
iScience. 2024 Sep 17;27(10):110971. doi: 10.1016/j.isci.2024.110971. eCollection 2024 Oct 18.
5
Preclinical evaluation of targeted therapies for central nervous system metastases.中枢神经系统转移的靶向治疗的临床前评估。
Dis Model Mech. 2024 Sep 1;17(9). doi: 10.1242/dmm.050836. Epub 2024 Sep 30.
6
Role of Gut Microbiota in Predisposition to Colon Cancer: A Narrative Review.肠道微生物群在结肠癌易感性中的作用：一项叙述性综述。
Indian J Microbiol. 2024 Sep;64(3):1-13. doi: 10.1007/s12088-024-01242-5. Epub 2024 Mar 29.
7
Theranostic nanoparticles for detection and treatment of pancreatic cancer.用于胰腺癌检测与治疗的诊疗纳米颗粒。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Jul-Aug;16(4):e1983. doi: 10.1002/wnan.1983.
8
Accumulation of liposomes in metastatic tumor sites is not necessary for anti-cancer drug efficacy.脂质体在转移性肿瘤部位的积累对于抗癌药物的疗效并非必需。
J Transl Med. 2024 Jul 3;22(1):621. doi: 10.1186/s12967-024-05428-9.
9
In vivo CRISPR screens reveal SCAF1 and USP15 as drivers of pancreatic cancer.体内 CRISPR 筛选揭示 SCAF1 和 USP15 是胰腺癌的驱动因子。
Nat Commun. 2024 Jun 20;15(1):5266. doi: 10.1038/s41467-024-49450-3.
10
Machine-learning and mechanistic modeling of metastatic breast cancer after neoadjuvant treatment.新辅助治疗后转移性乳腺癌的机器学习和机制建模。
PLoS Comput Biol. 2024 May 3;20(5):e1012088. doi: 10.1371/journal.pcbi.1012088. eCollection 2024 May.
本文引用的文献
1
An open letter to the FDA and other regulatory agencies: Preclinical drug development must consider the impact on metastasis.致美国食品药品监督管理局及其他监管机构的一封公开信：临床前药物研发必须考虑对转移的影响。
Clin Cancer Res. 2009 Jul 15;15:4529. doi: 10.1158/1078-0432.CCR-09-1363.
2
Finding the tumor copycat: approximating a human cancer.寻找肿瘤模仿者：模拟人类癌症
Nat Med. 2010 Sep;16(9):976-7. doi: 10.1038/nm0910-976.
3
Non-germline genetically engineered mouse models for translational cancer research.用于转化癌症研究的非种系基因工程小鼠模型。
Nat Rev Cancer. 2010 Jul;10(7):470-80. doi: 10.1038/nrc2877.
4
Raising the bar for cancer therapy models.提高癌症治疗模型的标准。
Nat Biotechnol. 2010 Jun;28(6):561-2. doi: 10.1038/nbt0610-561.
5
Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models.利用基因工程小鼠模型评估 Kras 突变型癌症的治疗反应。
Nat Biotechnol. 2010 Jun;28(6):585-93. doi: 10.1038/nbt.1640. Epub 2010 May 23.
6
Increased incidence of visceral metastases in scottish patients with BRCA1/2-defective ovarian cancer: an extension of the ovarian BRCAness phenotype.苏格兰 BRCA1/2 缺陷型卵巢癌患者内脏转移发生率增加：卵巢 BRCA 表型的扩展。
J Clin Oncol. 2010 May 20;28(15):2505-11. doi: 10.1200/JCO.2009.25.1082. Epub 2010 Apr 20.
7
Mouse models for breast cancer metastasis.乳腺癌转移的小鼠模型。
Biochem Biophys Res Commun. 2010 Apr 9;394(3):443-7. doi: 10.1016/j.bbrc.2010.03.070. Epub 2010 Mar 15.
8
Comparative impact of trastuzumab and cyclophosphamide on HER-2-positive human breast cancer xenografts.曲妥珠单抗和环磷酰胺对人 HER-2 阳性乳腺癌异种移植物的比较影响。
Clin Cancer Res. 2009 Oct 15;15(20):6358-66. doi: 10.1158/1078-0432.CCR-09-0931. Epub 2009 Oct 13.
9
Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks.伏立诺他在三阴性乳腺癌模型中抑制脑转移定植并诱导DNA双链断裂。
Clin Cancer Res. 2009 Oct 1;15(19):6148-57. doi: 10.1158/1078-0432.CCR-09-1039. Epub 2009 Sep 29.
10
VEGFR1-activity-independent metastasis formation.不依赖VEGFR1活性的转移形成
Nature. 2009 Sep 17;461(7262):E4; discussion E5. doi: 10.1038/nature08254.
Zotero 插件